关注
Jayaprakash Periyasamy
Jayaprakash Periyasamy
Cancer Science Institute of Singapore, NUS
在 nus.edu.sg 的电子邮件经过验证
标题
引用次数
引用次数
年份
Breast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras/PI3K inhibition
M Muthuswami, V Ramesh, S Banerjee, S Viveka Thangaraj, J Periasamy, ...
PloS one 8 (10), e77553, 2013
702013
Polyethylene glycol-modified gelatin/polylactic acid nanoparticles for enhanced photodynamic efficacy of a hypocrellin derivative in vitro
A Babu, J Periasamy, A Gunasekaran, G Kumaresan, S Naicker, ...
Journal of biomedical nanotechnology 9 (2), 177-192, 2013
252013
Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes
K Kalamohan, J Periasamy, DB Rao, GD Barnabas, S Ponnaiyan, ...
Molecular oncology 8 (7), 1306-1325, 2014
222014
Infectivity of adeno-associated virus serotypes in mouse testis
S Rajasekaran, J Thatte, J Periasamy, A Javali, M Jayaram, D Sen, ...
BMC biotechnology 18, 1-9, 2018
182018
Targeting phosphopeptide recognition by the human BRCA1 tandem BRCT domain to interrupt BRCA1-dependent signaling
J Periasamy, V Kurdekar, S Jasti, MB Nijaguna, S Boggaram, ...
Cell chemical biology 25 (6), 677-690. e12, 2018
182018
Upregulated, 7q21–22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer
S Tamilzhalagan, M Muthuswami, J Periasamy, MH Lee, SY Rha, P Tan, ...
Cellular Signalling 27 (6), 1075-1086, 2015
152015
Stratification and delineation of gastric cancer signaling by in vitro transcription factor activity profiling and integrative genomics
J Periasamy, M Muthuswami, DB Rao, P Tan, K Ganesan
Cellular Signalling 26 (5), 880-894, 2014
122014
Nimesulide and celecoxib inhibits multiple oncogenic pathways in gastric cancer cells
J Periasamy, M Muthuswami, V Ramesh, T Muthusamy, A Jain, ...
J Cancer Sci Ther 5 (4), 126-36, 2013
82013
Structure‐Guided synthesis and evaluation of small‐molecule inhibitors targeting protein–protein interactions of BRCA1 tBRCT domain
V Kurdekar, S Giridharan, J Subbarao, MB Nijaguna, J Periasamy, ...
ChemMedChem 14 (18), 1620-1632, 2019
52019
Structural features underlying the activity of benzimidazole derivatives that target phosphopeptide recognition by the tandem BRCT domain of the BRCA1 protein
V Kurdekar, S Giridharan, J Subbarao, MB Nijaguna, J Periasamy, ...
bioRxiv, 555623, 2019
22019
系统目前无法执行此操作,请稍后再试。
文章 1–10